A systematic approach to analysing gene-gene interactions: Polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 4, 2007, Pages 769-774

  Spurdle, Amanda B ^a   Chang, Jiun Horng ^b   Byrnes, Graham B ^b   Chen, Xiaoqing ^a   Dite, Gillian S ^b   McCredie, Margaret R E ^d   Giles, Graham G ^c   Southey, Melissa C ^b   Chenevix Trench, Georgia ^a   Hopper, John L ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CANCER EPIDEMIOLOGY CENTRE   (Australia)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; MICROSOME ENZYME;

ADULT; ARTICLE; AUSTRALIA; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INTERACTION; GENE LOCUS; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AUSTRALIA; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CONFOUNDING FACTORS (EPIDEMIOLOGY); EPOXIDE HYDROLASES; FEMALE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS;

EID: 34247525564     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0776     Document Type: Article

References (34)

1. Hopper JL, Southey MC, Dite GS, et al. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Cancer Epidemiol Biomarkers Prev 1999;8:741-7.
2. Easton D, Peto J. The contribution of inherited predisposition to cancer incidence. Cancer Surv 1990;9:395-416.
3. Rebbeck TR, Martinez ME, Sellers TA, et al. Genetic variation and cancer: improving the environment for publication of association studies. Cancer Epidemiol Biomarkers Prev 2004;13:1985-6.
4. Byrnes G, Gurrin L, Dowty J, et al. Publication policy or publication bias? Cancer Epidemiol Biomarkers Prev 2005;14:1363.
5. Oesch F. Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica 1973;3:305-40.
6. Adang AE, Meyer DJ, Brussee J, et al. Interaction of rat glutathione S-transferases 7-7 and 8-8 with γ-glutamyl- or glycyl-modified glutathione analogues. Biochem J 1989;264:759-64.
7. Hengstler JG, Arand M, Herrero ME, et al. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res 1998;154:47-85.
8. Strange RC, Fryer AA. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. In: Vineis P, editor. Metabolic polymorphisms and susceptibility to cancer no. 148. Lyon: IARC Scientific Publications; 1999. p. 231-49.
9. Hassett C, Aicher L, Sidhu JS, et al. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 1994;3:421-8. Erratum in: Hum Mol Genet 1994;3:1214.
10. Pemble S, Schroeder KR, Spencer SR, et al. Human glutathione S-transferase θ (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994;300:271-6.
11. Board PG. Biochemical genetics of glutathione-S-transferase in man. Am J Hum Genet 1981;33:36-43.
12. Seidegard J, Vorachek VVR, Pero RW, et al. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci U S A 1988;85: 7293-7.
13. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6:733-43.
14. Ahmad H, Wilson DE, Fritz RR, et al. Primary and secondary structural analyses of glutathione S-transferase π from human placenta. Arch Biochem Biophys 1990;278:398-408.
15. Harries LW, Stubbins MJ, Forman D, et al. Identification of genetic polymorphisms at the glutathione S-transferase π locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997;18:641-4.
16. Zimniak P, Nanduri B, Pikula S, et al. Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzvmic properties. Eur J Biochem 1994;224: 893-9.
17. Ali Osman F, Akande O, Antoun G, et al. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase π gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997;272:10004-12.
18. Johansson AS, Stenberg G, Widersten M, et al. Structure-activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105. J Mol Biol 1998;278:687-98.
19. Egan KM, Cai Q, Shu XO, et al. Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: results from the Shanghai Breast Cancer Study and meta-analysis. Cancer Epidemiol Biomarkers Prev 2004; 13:197-204.
20. Sull JW, Ohrr H, Kang DR, et al. Glutathione S-transferase M1 status and breast cancer risk: a meta-analysis. Yonsei Med J 2004;45:683-9.
21. Vogl FD, Taioli E, Maugard C, et al. Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2004;13:1473-9.
22. Sarmanova J, Susova S, Gut I, et al. Breast cancer: role of polymorphisms in biotransformation enzymes. Eur J Hum Genet 2004;12:848-54.
23. Hopper JL, Chenevix-Trench G, Jolley DJ, et al. Design and analysis issues in a population-based case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). J Natl Cancer Inst Monogr 1999;26:95-100.
24. Dite GS, Jenkins MA, Southey MC, et al. Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst 2003; 95:448-57.
25. McCredie MR, Dite GS, Giles GG, et al. Breast cancer in Australian women under the age of 40. Cancer Causes Control 1998;9:189-98.
26. Spurdle AB, Purdie DM, Webb PM, et al. The microsomal epoxide hydrolase Tyr113His polymorphism: association with risk of ovarian cancer. Mol Carcinog 2001;30:71-8.
27. Spurdle AB, Webb PM, Purdie DM, et al. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis 2001;22:67-72.
28. Clayton D, Hills M. Statistical models in epidemiology. Oxford; New York: Oxford University Press; 1993.
29. Agresti A. Categorical data analysis. New York; Brisbane: Wiley; 1990.
30. Terry PD, Goodman M. Is the association between cigarette smoking and breast cancer modified by genotype? A review of epidemiologic studies and meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:602-11.
31. Onay VU, Briollais L, Knight JA, et al. SNP-SNP interactions in breast cancer susceptibility. BMC Cancer 2006;6:114.
32. Little J, Simard J. CYP17 and breast cancer: no overall effect, but what about interactions? Breast Cancer Res 2005;7:238-42.
33. John EM, Hopper JL, Beck JC, et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 2004;6:R375-89.
34. Breast Cancer Association Consortium. Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst 2006;98:1382-96.